吉利德科学与美国政府就艾滋病药物达成10亿美元专利纠纷和解

格隆汇
16 Jan

格隆汇1月16日|据路透,根据周三提交给特拉华州联邦法院的一份文件,吉利德科学公司与美国政府就吉利德的艾滋病预防药物Truvada和Descovy达成了价值10亿美元的专利纠纷和解。此前,吉利德在2023年的陪审团审判中赢得了有关专利侵权的诉讼。吉利德总法律顾问Deborah Telman在一份声明中表示,该协议“公司继续将资源集中在其使命上,即发现、开发和向患有危及生命疾病的人提供创新疗法。”

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10